Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000

Ansar Hassan1, Hude Quan, Alice Newman

  • 1Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.

Insights

In-hospital mortality rates for valve surgery in Canada remained stable between 1994/95 and 1999/2000. However, significant differences in outcomes were observed across Canadian provinces for aortic valve replacement and mitral valve replacement procedures.

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Public Health

Background:

  • Limited scope of previous Canadian valve surgery outcome studies.
  • Need for comprehensive, national data on valve surgery outcomes.
  • Utilizing administrative data for large-scale health outcome analysis.

Purpose of the Study:

  • To report observed and risk-adjusted in-hospital mortality rates for aortic valve replacement (AVR) and mitral valve replacement (MVR) in Canada.
  • To analyze trends from 1994/95 to 1999/2000.
  • To identify interprovincial variations in outcomes.

Main Methods:

  • Analysis of hospital discharge abstract data from the Canadian Institute for Health Information (CIHI).
  • Inclusion of all AVR and MVR cases (1994/95-1999/2000), with or without concomitant coronary artery bypass grafting (CABG).
  • Risk adjustment using logistic regression for sociodemographic, comorbidity, and disease-specific factors.

Main Results:

  • Overall in-hospital mortality: 3.7% for isolated AVR, 5.7% for isolated MVR (excluding Quebec).
  • Stable risk-adjusted in-hospital mortality rates observed annually.
  • Significant interprovincial variation in mortality rates for both AVR (2.6%-6.8%) and MVR (2.5%-13.0%).

Conclusions:

  • In-hospital mortality following valve surgery in Canada has remained consistent over the study period.
  • Substantial provincial disparities in valve surgery outcomes exist.
  • This study offers the first extensive national overview of Canadian valve surgery outcomes.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...